Author: ALLISON GATLIN
Source
Two of Biogen’s newest drugs walloped first-quarter sales expectations on Wednesday, and could help Biogen stock reverse a recent downtrend.
The post Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock’s Decline? appeared first on Investor’s Business Daily.